Takeda Highlights Rare Neurological Disorder Programs In Wave 1
Company Already Has Pivoted Away From Larger Psychiatric Indications
Seeing significant unmet medical needs and insufficiently met needs in narcolepsy and rare types of epilepsy, Takeda has shifted its neuroscience focus.
